Safety and Efficacy of pTVG-HP Vaccine Combined with Nivolumab in Early, Recurrent Prostate Cancer

Abstract Purpose: We have previously reported that a plasmid DNA vaccine encoding prostatic acid phosphatase (pTVG-HP) had greater clinical activity when given in combination with pembrolizumab to patients with metastatic, castration-resistant prosta...